Orphazyme A/S acquired an additional unknown minority stake in CombiGene AB (OM:COMBI).
Orphazyme A/S (CPSE:ORPHA) completed the acquisition of an additional unknown minority stake in CombiGene AB (publ) (OM:COMBI) on February 21, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.43 SEK | -1.44% | -7.30% | +27.51% |
Mar. 13 | CombiGene's Epilepsy Project CG01 Receives Patent in Two New Countries | CI |
Feb. 21 | Orphazyme A/S acquired an additional unknown minority stake in CombiGene AB (OM:COMBI). | CI |
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
1,057 DKK | -1.42% | -3.47% | 5.48M | ||
3.43 SEK | -1.44% | -7.30% | 6.35M | ||
1st Jan change | Capi. | |
---|---|---|
+27.51% | 6.35M | |
+5.33% | 111B | |
+12.11% | 105B | |
-12.56% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.86% | 16.96B | |
+5.10% | 13.7B | |
+37.57% | 12.45B |